Efficacy and mode of action of mesalazine in the treatment of diarrhoea-predominant irritable bowel syndrome (IBS-D): study protocol for a randomised controlled trial

BACKGROUND: Irritable bowel syndrome (IBS) is reported by one in ten of the population accounting for up to 40% of new referrals to gastroenterology outpatients. Patients characteristically have abdominal discomfort and disturbed bowel habit. Diarrhoea-predominant IBS is characterised by frequent lo...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Leighton, Matthew P, Lam, Ching, Mehta, Samir, Spiller, Robin C
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2013
Aiheet:
Study Protocol
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3551830/
https://ncbi.nlm.nih.gov/pubmed/23302220
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1745-6215-14-10
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia